Deficient TP53 Expression, Function, and Cisplatin Sensitivity Are Restored by Quinacrine in Head and Neck Cancer

Jay Friedman(National Institute on Deafness and Other Communication Disorders), Carter Van Waes(National Institute on Deafness and Other Communication Disorders), Francisco G. Pernas(National Cancer Institute), Zhong Chen(Sun Yat-sen University), Bin Yan(Central South University), Xin Yang(Peking University), Praveen Duggal(National Institute on Deafness and Other Communication Disorders), Liesl Nottingham(National Institute on Deafness and Other Communication Disorders)
Clinical Cancer Research
November 15, 2007
Cited by 62


Related Papers